Skip to main content
SpringerLink
Log in
Book cover

Artificial Liver Support pp 121–131Cite as

Methods for the Assessment of Liver Function and Liver Regeneration

  • Chapter

  • 85 Accesses

Abstract

Fulminant hepatic failure is fatal if liver function is reduced to a level incompatible with survival. This truism needs some qualification. A fatal outcome may also be due to lack of adequate treatment of treatable complications, such as gastrointestinal hemorrhage, or to complications due] to interventions, such as septicemia from intravenous lines. This makes monitoring of liver function essential. Furthermore, monitoring of the factors determining liver function, viz., the rate of regeneration and degeneration of hepatocytes, is assumed to be of significance for assessment of the prognosis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Asakawa K, Hizuka N, Takano K, Horikawa R, Sukegawa I, Toyoda C, Shizume K (1989) Human growth hormone stimulates liver regeneration in rats. J Endocrinol Invest 12: 343–347

    PubMed  CAS  Google Scholar 

  2. Bernuau J, Goudeau A, Poynard T, Dubois S, Lesage G, Yvonnet B, Degott C, Bezeaud A, Rueff B, Benhamou J-P (1986) Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6: 648–651

    Article  PubMed  CAS  Google Scholar 

  3. Beutler B, Carami A (1987) Cachectin: more than a tumor necrosis factor. N Engl J Med 316: 379–385

    Article  PubMed  CAS  Google Scholar 

  4. Bissell DM, Choun MO (1988) The role of extracellular matrix in normal liver. Scand J Gastroenterol 23 (suppl 151): 1–7

    Article  Google Scholar 

  5. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N (1988) Transforming growth factor Beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 85: 1539–1543

    Article  PubMed  CAS  Google Scholar 

  6. Bucher NLR, Swaffield MN (1975) Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc Natl Acad Sci USA 72: 1157–1160

    Article  PubMed  CAS  Google Scholar 

  7. Christensen E (1989) Prognostication in primary biliary cirrhosis: relevance to the individual patient. Hepatology 10: 111–113

    Article  PubMed  CAS  Google Scholar 

  8. Christensen E, Bremmelgaard A, Bahnsen M, Andreasen PB, Tygstrup N (1984) Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol 19: 90–96

    PubMed  CAS  Google Scholar 

  9. Cornell RP (1985) Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration. Am J Physiol 249: R551–R562

    PubMed  CAS  Google Scholar 

  10. Decker K, Keppler D (1972) Galactosamine-induced liver injury. Prog Liver Dis 4: 183–199

    PubMed  CAS  Google Scholar 

  11. Derynck R (1988) Transforming growth factor alpha. Cell 54: 593–595

    Article  PubMed  CAS  Google Scholar 

  12. Desmet VJ, De Vos R (1984) Structural analysis of acute liver injury. In: Keppler D, Popper H, Bianchi L, Reutter W (eds) Mechanisms of hepatocyte injury and death. MTP Press, London, pp. 11–30

    Google Scholar 

  13. Diaz-Gil JJ, Sánchez G, Trilla C, Escartin P (1988) Identification of biliprotein as a liver growth factor. Hepatology 8: 484–486

    Article  PubMed  CAS  Google Scholar 

  14. Didolkar MS, Fitzpatrick JL, Elias EG, Whitley N, Keramati B, Suter CM, Brown S (1989) Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 169: 17–26

    PubMed  CAS  Google Scholar 

  15. Druker BJ, Mamón HJ, Roberts TM (1989) Onchogenesis, growth factors, and signal transduction. N Engl J Med 321: 1383–1391

    Article  PubMed  CAS  Google Scholar 

  16. Ekberg S, Carlsson L, Carlsson B, Billig H, Jansson J-O (1989) Plasma growth hormone pattern regulates epidermal growth factor ( EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver. Endocrinology 125: 2158–2166

    Article  PubMed  CAS  Google Scholar 

  17. Farrell G, Prendergast D, Murray M (1985) Halothane hepatitis. Detection of a constitutional susceptibility factor. N Engl J Med 313: 1310–1314

    Article  PubMed  CAS  Google Scholar 

  18. Fehlmann M, Canivet B, Freychet P (1981) Epidermal growth factor stimulates monovalent cation transport in isolated rat hepatocytes. Biochem Biophys Res Commun 100: 254–260

    Article  PubMed  CAS  Google Scholar 

  19. Francavilla A, Barone M, Todo S, Zeng Q, Porter KA, Starzl TE (1989) Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet ii: 1248–1249

    Google Scholar 

  20. Gerson RJ, Casini A, Gilfor D, Serroni A, Farber JL (1985) Oxygen-mediated cell injury in the killing of cultured hepatocytes by acetaminophen. Biochem Biophys Res Commun 126: 1129–1137

    Article  PubMed  CAS  Google Scholar 

  21. Goldberg M (1985) Purification and partial characterization of a liver cell proliferation factor called hepatopoietin. J Cell Biochem 27: 291–302

    Article  PubMed  CAS  Google Scholar 

  22. Hansen BA, Poulsen HE (1986) Changes in the hepatic capacity of urea-N synthesis, galactose elimination and antipyrine clearance following 70% hepatectomy in the rat. Scand J Clin Lab Invest 46: 233–237

    Article  CAS  Google Scholar 

  23. Jungermann K, Katz N (1989) Functional specialization of different hepatocyte populations. Physiol Rev 69: 708–764

    PubMed  CAS  Google Scholar 

  24. Kan M, Huang J, Mansson P-E, Yasumitsu H, Carr B, McKeehan WL (1989) Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc Natl Acad Sci USA 86: 7432–7436

    Article  PubMed  CAS  Google Scholar 

  25. Karavountzis GG, Redeker AG (1974) Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis. Ann Intern Med 80: 156–160

    Google Scholar 

  26. Krogsgaard K, Mathiesen LR, Aldershvile J, Kryger P, Andersson P, Hansson B-G, Nielsen JO, Ranek L, Copenhagen Hepatitis Acute Programme (1988) Delta infection and hepatitis B virus replication in Danish patients with fulminant hepatitis B. Scand J Infect Dis 20: 127–133

    Article  PubMed  CAS  Google Scholar 

  27. La Brecque DR, Steele G, Fogerty S, Wilson M, Barton J (1987) Purification and physical-chemical characterization of hepatic stimulator substance. Hepatology 7: 100–106

    Article  Google Scholar 

  28. Leffert HL, Koch KS, Morgan T, Rubalcava B (1979) Hormonal control of rat liver regeneration. Gastroenterology 76: 1470–1482

    PubMed  CAS  Google Scholar 

  29. Leffert HL, Koch KS, Shapiro P, Skelly H, Hubert J, Monken C, Lad PJ, Sala-Trepat J, Chisari FV (1987) Primary cultures, monoclonal antibodies and nucleic acid probes as tools for studies of hepatic structure and function. In: Tygstrup N, Orlandi F (eds) Cirrhosis of the liver: methods and fields of research. Elsevier, Amsterdam, pp 121–140

    Google Scholar 

  30. Leffert HL, Koch KS, Lad PJ, Shapiro IP, Skelly H, de Hemptinne B (1988) Hepatocyte regeneration, replication, and differentiation. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA (eds) The liver: biology and pathobiology. Raven, New York, pp. 833–849

    Google Scholar 

  31. Lipsky PE (1985) Role of interleukin-I in human B-cell activation. Contemp Top Mol Immunol 10: 195–217

    PubMed  CAS  Google Scholar 

  32. Marti U, Burwen SJ, Jones AL (1989) Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology 9: 126–138

    Article  PubMed  CAS  Google Scholar 

  33. Mead JE, Fausto N (1989a) Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 86: 1558–1562

    Article  PubMed  CAS  Google Scholar 

  34. Mead JE, Fausto N (1989b) Regulation of liver growth: protooncogenes and transforming growth factors. Lab Invest 60: 4–13

    PubMed  Google Scholar 

  35. Milandri M, Gaub J, Ranek L (1980) Evidence for liver cell proliferation during fatal acute liver failure. Gut 21: 423–427

    Article  PubMed  CAS  Google Scholar 

  36. O’Grady JG, Alexander GJM, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97: 439–445

    PubMed  Google Scholar 

  37. Okusawa S, Gelfand JA, Connolly RA, Dinarello CA (1987) Interleukin-I induces hemodynamic shock: reversal by a cyclooxygenase inhibitor. Fed Proc 46: 1200–1200

    Google Scholar 

  38. Perlmutter DH, Dinarello CA, Punsal P, Colten HR (1986) Cachectin/tumor necrosis factor regulates hepatic acute phase gene expression. J Clin Invest 78: 1349–1354

    Article  PubMed  CAS  Google Scholar 

  39. Petersen KF, Hansen BA, Poulsen HE (1987) Hepatic regeneration following glucagon treatment. Horm Metab Res 19: 239–241 129

    Google Scholar 

  40. Poulsen HE, Korsholm B (1984) Quantitative liver functions after administration of allyl alcohol to rats. Acta Pharmacol Toxicol 54: 120–123

    Article  CAS  Google Scholar 

  41. Poulsen HE, Vilstrup H, Keiding S (1984) Galactose elimination kinetics in perfused rat liver after two thirds hepatectomy. Scand J Clin Lab Invest 44: 155–158

    Article  PubMed  CAS  Google Scholar 

  42. Poulsen HE, Gaub J, Iversen J (1985) Changes in quantitative measures of hepatic function after 90% hepatectomy in rats. Eur J Clin Invest 15: 285–289

    Article  PubMed  CAS  Google Scholar 

  43. Poulsen HE, Pilsgaard H (1985) Antipyrine metabolism during hepatic regeneration in the rat. Liver 5: 196–199

    PubMed  CAS  Google Scholar 

  44. Ramse K, Buch Andreasen P, Ranek L (1980) Functioning liver mass in uncomplicated and fulminant acute hepatitis. Scand J Gastroenterol 15: 65–72

    Article  Google Scholar 

  45. Raper SE, Burwen SJ, Barker ME, Jones AL (1987) Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration. Gastroenterology 92: 1243–1250

    PubMed  CAS  Google Scholar 

  46. Rappaport RS, Dodge GR (1982) Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 155: 943–948

    CAS  Google Scholar 

  47. Rozengurt E (1986) Early signals in the mitogenic response. Science 234: 161–166

    Article  PubMed  CAS  Google Scholar 

  48. Russell WE, Coffey RJ, Ouellette AJ, Moses HL (1988) Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 85: 5126–5130

    Article  PubMed  CAS  Google Scholar 

  49. Scotto J, Opolon P, Et J, Vergoz D, Thomas M, Caroli J (1973) Liver biopsy and prognosis in liver failure. Gut 14: 927–933

    Article  PubMed  CAS  Google Scholar 

  50. Sinclair SB, Graig PD, Blendis LM, Abecassis M, Roberts EA, Phillips MJ, Cameron R, Levy GA (1989) Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. J Clin Invest 84: 1063–1069

    Article  CAS  Google Scholar 

  51. Skov Olsen P, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, Nexo E (1988) Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 8: 992–996

    Article  PubMed  CAS  Google Scholar 

  52. Sporn MB, Roberts AB (1988) Peptide growth factors are multifunctional. Nature 332: 217–219

    Article  PubMed  CAS  Google Scholar 

  53. Strain AJ (1988) Transforming growth factor beta and inhibition of hepatocellular proliferation. Scand J Gastroenterol 23, suppl. 151: 37–45

    Article  CAS  Google Scholar 

  54. Trey C, Lipworth L, Davidson CS (1970) Parameters influencing survival in the first 318 patients reported to the fulminant hepatic failure surveillance study. Gastroenterology 58: 306

    Google Scholar 

  55. Trump BF, Kim KM, Jones RT, Valigorsky JM (1976) Pathology of organelles in the human hepatic parenchymal cell. Prog Liver Dis 5: 51–68

    PubMed  CAS  Google Scholar 

  56. Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, Miyazaki H, Sugihara J, Tomita E, Muto Y, Daikuhara Y, Hashimoto S (1989) Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 9: 875–881

    Article  PubMed  CAS  Google Scholar 

  57. Tucker RF, Shipley GD, Moses HL (1984) Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science 226: 705–707

    Article  PubMed  CAS  Google Scholar 

  58. Tygstrup N, Ranek L (1986) Assessment of prognosis in fulminant hepatic failure. Sem Liver Dis 6: 129–137

    Article  CAS  Google Scholar 

  59. Tygstrup N, Vallo-Hansen F, Tonnesen K, Keiding S (1974) Kinetics of galactose metabolism in the perfused pig liver. In: Lundquist F, Tygstrup N (eds) Regulation of hepatic metabolism. Munksgaard, Copenhagen, pp. 314–323

    Google Scholar 

  60. Tygstrup N, Gaub J, Ranek L (1981) Determination of liver function and liver regeneration in fulminant hepatic failure. In: Brunner G, Schmidt FW (eds) Artificial liver support. Springer Verlag, Berlin Heidelberg New York, pp. 39–45

    Google Scholar 

  61. Ulshen MH, Lyn-Cook LE, Raasch RH (1986) Effects of intraluminal epidermal growth factor on mucosal proliferation in the small intestine of adult rats. Gastroenterology 91: 1134–1140

    PubMed  CAS  Google Scholar 

  62. Vilstrup H, Iversen J, Tygstrup N (1986) Glucoregulation in acute liver failure. Eur J Clin Invest 16: 193–197

    Article  PubMed  CAS  Google Scholar 

  63. Vizzotto L, Romani F, Ferrario VF, Degna CT, Aseni P (1989) Characterization by morphometric model of liver regeneration in the rat. Am J Anat 185: 444–454

    Article  PubMed  CAS  Google Scholar 

  64. Yildirim SI, Poulsen HE (1981) Quantitative liver functions after 70% hepatectomy. Eur J Clin Invest 11: 469–472

    Article  PubMed  CAS  Google Scholar 

  65. Zapf J, Rinderknecht E, Humbel RE (1978) Non-suppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implication. Metabolism 27: 1803–1827

    Article  PubMed  CAS  Google Scholar 

  66. Zieve FJ, Zieve L, Doizaki WM, Gilsdorf RB (1974) Synergism between ammonia and fatty acids in the production of coma: implications for hepatic coma. J Pharmacol Exp Ther 191: 10–16 131

    Google Scholar 

  67. Zimmerman HJ, Ishak KG (1982) Valporate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 2: 591–597

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. N. Tygstrup
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Gastroenterologie und Hepatologie, Medizinische Hochschule Hannover Krankenhaus Oststadt, Podbielskistraße 380, W-3000, Hannover 51, Germany

    G. Brunner

  2. Second Department of Surgery, Asahikawa Medical College Nishi-Kagura, Asahikawa, 078, Hokkaido, Japan

    M. Mito

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tygstrup, N. (1992). Methods for the Assessment of Liver Function and Liver Regeneration. In: Brunner, G., Mito, M. (eds) Artificial Liver Support. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77359-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77359-4_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77361-7

  • Online ISBN: 978-3-642-77359-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation